META Region Regulatory Affairs Updates at a glance

About this course

In this course, we will master the challenges of the regulatory affairs profession worldwide, especially in the META region. The region has experienced and is still experiencing many updates and variations in the guidelines and requirements for practicing regulatory affairs, Pharmacovigilance, and pharmaco-economics.The META region, which includes the GCC, Africa, and the Levant, has its leader in the area. The leader of the region is a country that follows strictly any one of the globally well-known health authoritiesWhat will you learn?Keep an eye on the updatesPharmaceutical products and medical devices updatesFocus on Saudi Arabia the META region leader updates Tawoon system updates   Prepare in advance for any regulatory changes Prepare the risk mitigation plan Screen the updates in each country Predict the changes in other relevant countries For Example, Saudi Arabia, the GCC region's leader, strictly follows the US's FDA, and Jordan the leader of the Levant area, follows Saudi Arabia. In contrast, Tunisia follows the EMA of Europe.The regulatory affairs profession in the META (Middle East, Turkey, and Africa) region presents unique challenges due to the dynamic and evolving landscape of guidelines and requirements in pharmacovigilance, pharmaco-economics, and overall regulatory practice. Success in this region hinges on a proactive and strategic approach to monitoring regulatory updates from key leader countries.The META region's regulatory framework is largely influenced by leading nations, each adhering to globally recognized health authorities. For instance, Saudi Arabia, a leader in the GCC, often aligns with the US FDA, while Jordan, in the Levant, frequently mirrors Saudi Arabian regulations. Tunisia, conversely, follows the EMA of Europe. This hierarchical structure means that updates in th

Course objectives

• Prepare for upcoming regulatory changes in the META region
• Identify and analyze updates specific to pharmaceutical products and medical devices
• Predict potential regulatory shifts in neighboring countries